Syneron Medical Stock Price, News & Analysis (NASDAQ:ELOS)

$11.00 0.00 (0.00 %)
(As of 12/14/2017 04:00 PM ET)
Previous Close$11.00
Today's Range$11.00 - $11.00
52-Week Range$6.18 - $11.43
Volume3,905 shs
Average Volume562,777 shs
Market Capitalization$387.56 million
P/E RatioN/A
Dividend YieldN/A
Beta1.25

About Syneron Medical (NASDAQ:ELOS)

Syneron Medical logoSyneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company's aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments. The Company's products target a range of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, tattoo removal, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, and laser-assisted lipolysis.

Receive ELOS News and Ratings via Email

Sign-up to receive the latest news and ratings for ELOS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:ELOS
CUSIPN/A
Phone+972-7-32442200

Debt

Debt-to-Equity RatioN/A
Current Ratio2.68%
Quick Ratio1.84%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net Margins-1.09%
Return on Equity-1.74%
Return on Assets-1.30%

Miscellaneous

Employees817
Outstanding Shares35,230,000

Syneron Medical (NASDAQ:ELOS) Frequently Asked Questions

What is Syneron Medical's stock symbol?

Syneron Medical trades on the NASDAQ under the ticker symbol "ELOS."

How were Syneron Medical's earnings last quarter?

Syneron Medical Ltd. (NASDAQ:ELOS) released its quarterly earnings results on Thursday, August, 4th. The medical equipment provider reported $0.09 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.06 by $0.03. The medical equipment provider earned $75 million during the quarter, compared to analysts' expectations of $75.72 million. Syneron Medical had a negative net margin of 1.09% and a negative return on equity of 1.74%. The business's quarterly revenue was up 2.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.07 earnings per share. View Syneron Medical's Earnings History.

Where is Syneron Medical's stock going? Where will Syneron Medical's stock price be in 2017?

1 Wall Street analysts have issued 12-month price objectives for Syneron Medical's shares. Their forecasts range from $11.00 to $11.00. On average, they expect Syneron Medical's stock price to reach $11.00 in the next twelve months. View Analyst Ratings for Syneron Medical.

Who are some of Syneron Medical's key competitors?

Who are Syneron Medical's key executives?

Syneron Medical's management team includes the folowing people:

  • Shimon Eckhouse Ph.D., Chairman of the Board
  • Amit Meridor, Chief Executive Officer
  • , Bio & Compensation - 
  • Hugo Goldman, Chief Financial Officer
  • , Bio & Compensation - 
  • Erik Dowell, Vice President-North America
  • William Griffing, Chief Executive Officer - Syneron Candela North America
  • Shlomo Alkalay, Chief Operating Officer
  • Lisa A. Soderquist, Chief Human Resource Officer
  • , Bio & Compensation - 
  • Robert Ruck, Executive Vice President, Asia Pacific
  • Robert Fielitz, Vice President and Managing Director of Europe, Middle East and Africa
  • Sarit Soccary Ben-Yochanan, Vice President - Business Development & Strategy

Who owns Syneron Medical stock?

Syneron Medical's stock is owned by a number of of institutional and retail investors. Top institutional investors include Brandes Investment Partners LP (8.24%). View Institutional Ownership Trends for Syneron Medical.

Who sold Syneron Medical stock? Who is selling Syneron Medical stock?

Syneron Medical's stock was sold by a variety of institutional investors in the last quarter, including Brandes Investment Partners LP. View Insider Buying and Selling for Syneron Medical.

How do I buy Syneron Medical stock?

Shares of Syneron Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Syneron Medical's stock price today?

One share of Syneron Medical stock can currently be purchased for approximately $11.00.

How big of a company is Syneron Medical?

Syneron Medical has a market capitalization of $387.56 million. Syneron Medical employs 817 workers across the globe.

How can I contact Syneron Medical?

Syneron Medical's mailing address is Tavor Building 4 P.O. Box 550, YOKNEAM, 2069200, Israel. The medical equipment provider can be reached via phone at +972-7-32442200.


MarketBeat Community Rating for Syneron Medical (ELOS)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  154 (Vote Outperform)
Underperform Votes:  93 (Vote Underperform)
Total Votes:  247
MarketBeat's community ratings are surveys of what our community members think about Syneron Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Syneron Medical (NASDAQ:ELOS) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.332.332.332.33
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $10.60$10.60$10.60$10.60
Price Target Upside: 2.30% downside2.30% downside2.30% downside2.30% downside

Syneron Medical (NASDAQ:ELOS) Consensus Price Target History

Price Target History for Syneron Medical (NASDAQ:ELOS)

Syneron Medical (NASDAQ:ELOS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/12/2017Maxim GroupDowngradeBuy -> Hold$12.00 -> $11.00MediumView Rating Details
10/24/2016Brean CapitalReiterated RatingBuyN/AView Rating Details
8/5/2016Leerink SwannDowngradeOutperform -> Market Perform$9.40 -> $7.80N/AView Rating Details
(Data available from 12/14/2015 forward)

Earnings

Syneron Medical (NASDAQ:ELOS) Earnings History and Estimates Chart

Earnings by Quarter for Syneron Medical (NASDAQ:ELOS)

Syneron Medical (NASDAQ ELOS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/15/2017Q416$0.03($0.03)$82.02 million$82.90 millionViewListenView Earnings Details
11/9/2016Q316($0.02)$0.02$68.08 million$71.50 millionViewListenView Earnings Details
8/4/2016Q216$0.06$0.09$75.72 million$75.00 millionViewListenView Earnings Details
5/19/2016Q116$0.01$0.04$64.38 million$68.70 millionViewListenView Earnings Details
2/22/2016Q415$0.07$0.07$75.56 million$78.90 millionViewListenView Earnings Details
11/11/2015Q315$0.03$0.03$66.60 million$62.10 millionViewListenView Earnings Details
8/4/2015Q215$0.06$0.04$70.93 million$73.50 millionViewN/AView Earnings Details
5/13/2015Q115$0.01$0.02$62.08 million$63.40 millionViewListenView Earnings Details
2/18/2015Q414$0.06$0.09$71.42 million$74.10 millionViewN/AView Earnings Details
11/12/2014Q314$0.03$0.03$58.32 million$60.30 millionViewN/AView Earnings Details
8/6/2014Q214$0.07$0.07$63.52 million$64.60 millionViewListenView Earnings Details
5/14/2014Q114$0.04$0.04$55.50 million$56.80 millionViewN/AView Earnings Details
2/20/2014Q413$0.08$0.11$65.70 million$64.30 millionViewListenView Earnings Details
11/13/2013Q313$0.01$0.04$62.06 million$62.70 millionViewListenView Earnings Details
8/14/2013Q2 2013$0.09$0.02$70.93 million$68.80 millionViewN/AView Earnings Details
5/22/2013Q1 2013$0.02$0.02$61.19 million$61.20 millionViewN/AView Earnings Details
2/12/2013Q4 2012$0.09$0.11$70.60 million$72.80 millionViewN/AView Earnings Details
11/7/2012Q312$0.04$0.03$65.51 million$60.13 millionViewN/AView Earnings Details
8/15/2012$0.04$0.05ViewN/AView Earnings Details
2/9/2012$0.04$0.03ViewN/AView Earnings Details
11/10/2011($0.09)($0.03)ViewN/AView Earnings Details
8/11/2011($0.02)($0.01)ViewN/AView Earnings Details
5/19/2011($0.04)$0.01ViewN/AView Earnings Details
2/16/2011($0.04)$0.24ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Syneron Medical (NASDAQ:ELOS) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Syneron Medical (NASDAQ:ELOS)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Syneron Medical (NASDAQ ELOS)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Syneron Medical (NASDAQ ELOS) News Headlines

Source:
DateHeadline
Sientra (SIEN) versus Syneron Medical (ELOS) Critical ReviewSientra (SIEN) versus Syneron Medical (ELOS) Critical Review
www.americanbankingnews.com - November 7 at 10:58 AM
Head to Head Contrast: Syneron Medical (ELOS) and Its CompetitorsHead to Head Contrast: Syneron Medical (ELOS) and Its Competitors
www.americanbankingnews.com - September 20 at 2:23 PM
Intersect ENT (XENT) versus Syneron Medical (ELOS) Head to Head ComparisonIntersect ENT (XENT) versus Syneron Medical (ELOS) Head to Head Comparison
www.americanbankingnews.com - September 19 at 2:30 PM
Comparing Syneron Medical (ELOS) & Align Technology (ALGN)Comparing Syneron Medical (ELOS) & Align Technology (ALGN)
www.americanbankingnews.com - July 27 at 9:10 AM
Syneron Candela Completes Previously Announced Transaction with Funds Advised by Apax Partners and Becomes a Private CompanySyneron Candela Completes Previously Announced Transaction with Funds Advised by Apax Partners and Becomes a Private Company
finance.yahoo.com - July 17 at 11:14 AM
Medtech Mergers Surge AgainMedtech Mergers Surge Again
seekingalpha.com - July 10 at 11:12 PM
ETFs with exposure to Syneron Medical Ltd. : July 10, 2017ETFs with exposure to Syneron Medical Ltd. : July 10, 2017
finance.yahoo.com - July 10 at 6:07 PM
Syneron Medical Ltd. breached its 50 day moving average in a Bearish Manner : ELOS-US : July 7, 2017Syneron Medical Ltd. breached its 50 day moving average in a Bearish Manner : ELOS-US : July 7, 2017
finance.yahoo.com - July 8 at 10:29 AM
Syneron Candela (ELOS) Announces Expiration of Go-Shop PeriodSyneron Candela (ELOS) Announces Expiration of Go-Shop Period
www.streetinsider.com - May 10 at 5:06 PM
Apax to buy Israeli aesthetic device firm Syneron for $397 mlnApax to buy Israeli aesthetic device firm Syneron for $397 mln
us.rd.yahoo.com - April 3 at 10:17 PM
Apax to buy Israeli aesthetic device firm Syneron for $397 millionApax to buy Israeli aesthetic device firm Syneron for $397 million
us.rd.yahoo.com - April 3 at 10:17 PM
Syneron Medical (ELOS) Jumps on Apax DealSyneron Medical (ELOS) Jumps on Apax Deal
www.baystreet.ca - April 3 at 5:16 PM
Syneron Medical Agrees To Be Bought By Apax Partners For $397 Mln - Quick FactsSyneron Medical Agrees To Be Bought By Apax Partners For $397 Mln - Quick Facts
www.nasdaq.com - April 3 at 5:16 PM
Syneron Medical Ltd. stock rises after nearly $400 mln acquisition of outstanding sharesSyneron Medical Ltd. stock rises after nearly $400 mln acquisition of outstanding shares
www.marketwatch.com - April 3 at 5:16 PM
Apax eyes IPO for investment house Psagot in Tel Aviv -sourceApax eyes IPO for investment house Psagot in Tel Aviv -source
uk.finance.yahoo.com - April 3 at 7:18 AM
Apax close to $500 mln deal to buy Israels Syneron - reportsApax close to $500 mln deal to buy Israel's Syneron - reports
uk.finance.yahoo.com - April 2 at 8:31 AM
Form 6-K Syneron Medical Ltd. For: Mar 27 - StreetInsider.comForm 6-K Syneron Medical Ltd. For: Mar 27 - StreetInsider.com
www.streetinsider.com - March 28 at 9:40 PM
Syneron Medical: Still Frustrating - And Still Tantalizing - Seeking AlphaSyneron Medical: Still Frustrating - And Still Tantalizing - Seeking Alpha
seekingalpha.com - February 24 at 5:43 PM
Syneron Medical 4Q Loss 3 Cents a Share (ELOS)Syneron Medical 4Q Loss 3 Cents a Share (ELOS)
www.investopedia.com - February 16 at 4:40 PM
Syneron Medical Reports Fourth Quarter 2016 Revenue of $82.9 Million and Full Year 2016 Revenue $298.1 MillionSyneron Medical Reports Fourth Quarter 2016 Revenue of $82.9 Million and Full Year 2016 Revenue $298.1 Million
us.rd.yahoo.com - February 16 at 4:40 PM
7:02 am Syneron Medical beats by $0.05, beats on revs7:02 am Syneron Medical beats by $0.05, beats on revs
us.rd.yahoo.com - February 16 at 4:40 PM
Q4 2016 Syneron Medical Ltd Earnings Release - Before Market OpenQ4 2016 Syneron Medical Ltd Earnings Release - Before Market Open
us.rd.yahoo.com - February 16 at 4:40 PM
Syneron Medical Reports 4Q Loss of 3 Cents a ShareSyneron Medical Reports 4Q Loss of 3 Cents a Share
www.investopedia.com - February 16 at 4:40 PM
UPDATE 2-Hologic buys Cynosure to expand into medical aesthetics - NasdaqUPDATE 2-Hologic buys Cynosure to expand into medical aesthetics - Nasdaq
www.nasdaq.com - February 14 at 5:51 PM
Sientra (SIEN) Names Philippe Schaison to Board of DirectorsSientra (SIEN) Names Philippe Schaison to Board of Directors
www.streetinsider.com - February 7 at 6:06 PM
Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources - PR Newswire (press release)Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources - PR Newswire (press release)
www.prnewswire.com - January 31 at 5:37 PM

SEC Filings

Syneron Medical (NASDAQ:ELOS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Syneron Medical (NASDAQ:ELOS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Syneron Medical (NASDAQ ELOS) Stock Chart for Thursday, December, 14, 2017

Loading chart…

This page was last updated on 12/14/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.